A randomized trial comparing concurrent chemoradiotherapy with single-agent cisplatin versus cisplatin plus gemcitabine in patients with advanced cervical cancer: An Asian Gynecologic Oncology Group study. (Q33421615)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A randomized trial comparing concurrent chemoradiotherapy with single-agent cisplatin versus cisplatin plus gemcitabine in patients with advanced cervical cancer: An Asian Gynecologic Oncology Group study.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25827291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

A randomized trial comparing concurrent chemoradiotherapy with single-agent cisplatin versus cisplatin plus gemcitabine in patients with advanced cervical cancer: An Asian Gynecologic Oncology Group study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25827291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

chemoradiotherapy

0 references

gynecologic oncology

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

cervix uterine cancer

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25827291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25827291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Chyong-Huey Lai

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25827291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Chun-Chieh Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25827291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Hung-Hsueh Chou

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25827291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Hao Lin

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25827291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Wen-Shiung Liou

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25827291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Chih-Wen Tseng

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25827291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Jui-Der Liou

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25827291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Kuan-Gen Huang

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25827291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Huei-Jean Huang

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25827291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Eng-Yen Huang

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25827291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Chien-Hsun Chen

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25827291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Ting-Chang Chang

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25827291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Chee-Jen Chang

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25827291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Ji-Hong Hong

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25827291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

language of work or name

0 references

publication date

28 March 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25827291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25827291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

137

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25827291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25827291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

462-467

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25827291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.046

7 January 2021

Concurrent chemoradiation for locally advanced carcinoma of the cervix: where are we in 2006?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.046

7 January 2021

Chemoradiation in the management of cervix cancer: current status and future directions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.046

7 January 2021

Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.046

7 January 2021

Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group stud

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.046

7 January 2021

Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.046

7 January 2021

The role of gemcitabine in the treatment of other tumours

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.046

7 January 2021

Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.046

7 January 2021

Concurrent cisplatin/gemcitabine chemotherapy along with radiotherapy in locally advanced cervical carcinoma: a phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.046

7 January 2021

Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.046

7 January 2021

Standardized uptake value in para-aortic lymph nodes is a significant prognostic factor in patients with primary advanced squamous cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.046

7 January 2021

A prospective randomized trial to study the impact of pretreatment FDG-PET for cervical cancer patients with MRI-detected positive pelvic but negative para-aortic lymphadenopathy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.046

7 January 2021

Risk stratification of patients with advanced squamous cell carcinoma of cervix treated by radiotherapy alone

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.046

7 January 2021

Phase I trial of strictly time-scheduled gemcitabine and cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.046

7 January 2021

A phase I-II study of weekly cisplatin and gemcitabine with concurrent radiotherapy in locally advanced cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.046

7 January 2021

Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.046

7 January 2021

A matched-case comparison to explore the role of consolidation chemotherapy after concurrent chemoradiation in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.046

7 January 2021

Phase III randomized trial of weekly cisplatin and irradiation versus cisplatin and tirapazamine and irradiation in stages IB2, IIA, IIB, IIIB, and IVA cervical carcinoma limited to the pelvis: a Gynecologic Oncology Group study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.046

7 January 2021

Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: a phase I trial of the Puget Sound Oncology Consortium.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.046

7 January 2021

A phase I study of gemcitabine followed by cisplatin concurrent with whole pelvic radiation therapy in locally advanced cervical cancer: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.046

7 January 2021

Identifiers

10.1016/J.YGYNO.2015.03.046

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25827291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25827291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33421615&oldid=2043642913"